Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$342K Buy
1,283
+125
+11% +$34.6K 0.02% 319
2025
Q4
$319K Sell
1,158
-152
-12% -$42.6K 0.01% 321
2025
Q3
$378K Buy
1,310
+56
+4% +$16.6K 0.02% 257
2025
Q2
$415K Sell
1,254
-145
-10% -$46.7K 0.02% 229
2025
Q1
$460K Sell
1,399
-35
-2% -$10.5K 0.03% 198
2024
Q4
$396K Sell
1,434
-30
-2% -$9.56K 0.02% 229
2024
Q3
$507K Buy
1,464
+4
+0.3% +$1.38K 0.03% 196
2024
Q2
$482K Buy
1,460
+177
+14% +$61K 0.03% 181
2024
Q1
$466K Buy
1,283
+44
+4% +$14.5K 0.03% 175
2023
Q4
$371K Buy
1,239
+21
+2% +$6.14K 0.03% 188
2023
Q3
$348K Buy
1,218
+56
+5% +$16K 0.03% 183
2023
Q2
$326K Buy
1,162
+42
+4% +$10.9K 0.03% 195
2023
Q1
$286K Buy
+1,120
New +$326K 0.03% 206

Other funds holding CI

McAdam LLC's CI Position: Q1 2026 in Review

McAdam LLC increased its Cigna (CI) stake by 11% in Q1 2026, buying an estimated $34.6K and bringing the position to 1,283 shares worth $342K. The position accounts for 0.02% of the portfolio, ranked #319.

McAdam LLC first reported a position in CI in Q1 2023 and has held it in 13 quarters since. The position peaked at $507K in Q3 2024. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • McAdam LLC held 1,283 shares of Cigna worth $342K as of Q1 2026.
  • McAdam LLC bought 125 Cigna shares in Q1 2026, an estimated $34.6K.
  • Cigna made up 0.02% of McAdam LLC's portfolio in Q1 2026, its #319 holding.
  • McAdam LLC first reported a position in Cigna in Q1 2023 and has held it in 13 quarters since.
  • McAdam LLC's Cigna position peaked at $507K in Q3 2024.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on McAdam LLC's 13F filing for Q1 2026, filed 8 May 2026.